Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer: A protocol of systematic review and meta-analysis

BACKGROUND: The aim of this study is to examine the efficacy of weekly amrubicin (WA) for treating refractory or relapsed non-small cell lung cancer (RRNSCLC). METHODS: The literature search will be performed using the Cochrane Library, MEDLINE, EMBASE, CINAHL, PsycINFO, Scopus, Chinese Biomedical L...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Dong, Jiang, Chao, Xie, Ming-rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310864/
https://www.ncbi.nlm.nih.gov/pubmed/32569168
http://dx.doi.org/10.1097/MD.0000000000020454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310864/
https://www.ncbi.nlm.nih.gov/pubmed/32569168
http://dx.doi.org/10.1097/MD.0000000000020454

Ejemplares similares